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Domestic violence and abuse (DVA) is a major public health and clinical challenge. The prevalence of 
sexual health problems is substantially higher in abused than non-abused men and women. NICE 
guidelines advocate routine enquiry about DVA in sexual health clinics. We aim to provide the 
clinician with practical guidance on how to appropriately ask about and respond to DVA, 
complementing the recently published BASHH guidance on domestic abuse and also introducing IRIS 
ADViSE, an evidence-based model, providing a specific framework for DVA training, support and 
referrals to specialist DVA advocate-educators. This supports clinicians to be clinically competent by 
enquiring about DVA, as well as ensuring that this enquiry is compassionate and safe. 
  
Introduction 
Domestic violence and abuse (DVA) is a violation of human rights with profound physical, emotional, 
and socioeconomic costs to the individual, families, communities and society as a whole. In the UK, 
28.3% of women and 14.7% of men had experienced any domestic abuse since the age of 16 (1). 
DVA costs the NHS £1.7 billion annually, excluding mental health costs; the estimated overall annual 
cost of DVA in the UK is £15.7 billion (2). The prevalence of all DVA is higher among women than 
men. Women also experience much more sexual abuse, as well as more severe and repeated 
physical abuse and more coercive control (1). The majority of epidemiological and intervention 
research on DVA has been in women in heterosexual relationships not men or LGBT communities,  
though they are also affected by DVA.  
 
What is Domestic Violence and Abuse?  
The UK cross-government definition of DVA is any incident or pattern of incidents of controlling, 
coercive, threatening behaviour, violence or abuse between those aged 16 or over who are, or have 
been, intimate partners or family members regardless of gender or sexuality. The abuse can 
encompass, but is not limited to psychological, physical, sexual, financial and emotional (3). Intimate 
partner violence (IPV) forms the majority of DVA and is defined as any behaviour within an intimate 
relationship that causes physical, psychological, or sexual harm to those in the relationship (4). It is 
not necessary to be co-habiting for IPV to occur.  
 
Health impact 
DVA damages physical and psychological health In the UK, two women are killed by their current or 
former male partner each week (5) and is tallied by the ‘Counting Dead Women’ twitter campaign in 
the UK (6). In the USA, 5.3 million episodes of IPV occur each year, causing 2 million injuries, with 
550 000 victims requiring medical treatment (7). In Australia, IPV is the biggest contributor to death, 
disability, and illness for women of reproductive age, ranking above high blood pressure, smoking, 
illicit drug use, and obesity (8).   
 
Presentations of DVA in sexual health settings include gynaecological problems, substance abuse, 
self-harm, suicidal ideation, anxiety and depression, and chronic pain conditions (9) (10). The biggest 
and most consistent physical health difference between abused and non-abused women are 
gynaecological problems.  Specific associations include sexually transmitted infections, abnormal 
vaginal discharge, chronic pelvic pain, unplanned pregnancy and induced abortion (10) (11). Sexual 
health problems indicating DVA affecting men and women patients include sexual risk taking, sexual 
dysfunction and inconsistent condom use (12).  
 
DVA Enquiry 
NICE identifies sexual health clinics as a setting in which routine enquiry about DVA should be 
considered best practice due to the high frequency of presentations and outcomes associated with 
DVA in sexual and reproductive health care (13). 
 
IRIS (Identification and Referral to Improve Safety) describes in detail multiple aspects of best 
practice for the healthcare response to DVA, including enquiry. IRIS has its roots in strong evidence 
from a cluster randomised controlled trial in primary care (14) and promising findings from a 
feasibility study in sexual health. In primary care, IRIS has now been commissioned in 33 localities.  
The IRIS intervention is made up of clinically focused training sessions, a DVA clinical champion or 
lead to promote DVA enquiry and provide support to staff, patient information including numbers 
for DVA services in the form of posters and discrete cards, and a simple referral pathway for 
specialist support. This is as recommended by the BASHH guidance on DVA (15).   
 
IRIS in addition to this, includes specifically adapting the electronic records, by using the HARK 
acronym (see Box 1), to prompt enquiry and safely record disclosures. HARK also reminds clinicians 
to consider all the dimensions of abuse: not just physical, but also sexual and emotional (16). 
Emotional abuse, even alone, has been found to produce long-term adverse physical and mental 
health effects. It also includes a question about fear, which is indicative of coercive control. Coercive 
control is now formally included as a criminal offence alongside threats to kill, harassment, stalking 
and putting people in fear of violence. Asking a single question such as “Have you ever been hit by 
your partner?” is too limited, missing abuse, as well as illegal behaviours. 
 
IRIS ADViSE (Assessing for Domestic Violence in Sexual health Environments) is the IRIS model 
developed for sexual health. This has been evaluated using an adaptive pilot study in two sites by 
the authors of this article, showing that it is feasible, and appears to increase rates of enquiry, 
identification and referrals for advocacy (17).   
 
Promoting and managing disclosure 
The steps recommended in this article are consistent with the BASHH guidance (15) and informed by 
the authors’ joint experience of implementing IRIS and IRIS ADViSE. 
 
Step 1: ASK 
Clinicians sometimes express concern about asking about DVA as they are worried about making a 
patient uncomfortable. However, systematic reviews of questionnaire and interview-based studies 
of women show that enquiring about IPV is generally acceptable (18). In one study, women 
emphasised that they viewed being asked about IPV as an opportunity to receive information and 
support rather than solely as a method to identify IPV (19).  
 
Certain factors promote the likelihood of disclosure. These are usually already practised in sexual 
and reproductive health care when enquiring about other potentially sensitive issues, such as 
sexuality and sexual behaviours. These include:  
 Creating a safe and confidential environment by seeing patients alone (including without 
young children as they may report back to a controlling partner) 
 Being non-judgemental and showing compassion  
 Giving a reason for asking (association with a particular symptom/diagnosis or the ability of 
the service to offer tailored support) 
 Not pressuring a patient to disclose. 
 
It is important for the clinician to avoid asking about DVA as a “tick-box” exercise. Open questions 
are a good starting point.  An appropriate time to enquire about abuse could be when discussing 
partners as part of a sexual history, following cues when the patient mentions intimate or family 
relationships, or relating it to specific presentations. The latter method may promote disclosure as it 
can help patients understand the clinical relevance of these questions. Some useful questions are 




Step 2 RESPOND 
This has two components:  
 
a) VALIDATE 
Patients who disclose have frequently harbored fears of, or previously experienced, being judged or 
not believed. The clinician should validate the patient’s experience by saying that they believe them, 
asserting that the perpetrator’s behavior is unacceptable and sometimes criminal, and offering 
support. Possible validation statements are listed in Box 2. It is helpful to explain that DVA can 
damage health, is not limited to physical abuse, and support that is offered can improve health, 
safety and wellbeing.  
 
Box 1 ASK 
 
“How are things at home?”  
“Has anyone at home/your partner made you feel unsafe or threatened?”  
“Are you afraid of anyone at home/your partner?”  
“Patients with this symptom/condition may be suffering abuse from a partner or 
adult they live with; is that something you have ever experienced?” 
 
H HUMILIATION  
 
Have you been humiliated or emotionally abused in other ways by your 
partner or your ex-partner? 
 
A AFRAID  
 




Have you been raped or forced to have any kind of sexual activity by 




Have you been kicked, hit, slapped or otherwise physically hurt by your 
partner or ex-partner? 
  
b) ASSESS 
The clinician should make a brief assessment of immediate safety. Phrases such as “Are you safe to 
go home?” or “Are either you or your children in immediate danger?” are explicit. Other ways of 
exploring this includes asking about increasing frequency or severity of violence, and whether a 
perpetrator can access weapons. Escalating physical violence and access to weapons are major risk 
factors for fatal violence. If there is any suggestion of immediate harm, then the patient should be 
helped to urgently contact a specialist DVA service or the police. There should be a private room 
available for the patient to wait without fear of being found or overheard by a perpetrator.  
 
 
STEP 3 ACTION 
All patients who disclose DVA should be offered a referral to local and/or national specialist DVA 
advocacy services regardless of the type of abuse and the timescale over which it has happened. 
Even if patients decline referrals, they will know that they can discuss the problem at the clinic, be 
aware of help available and can self-refer or request a referral when they feel ready. A simple 
referral pathway saves clinicians’ time. It requires readily available details of local and national 
services, including the free phone 24-hour national domestic violence helpline run by Women’s Aid 
and Refuge (0808 2000247). The local authority normally has a domestic violence coordinator with 
knowledge of the local services available. A contact should be identified in local services to facilitate 
direct referrals to domestic violence advocates and support clinicians managing DVA.  
 
BOX 2 VALIDATE 
  
“Everybody has the right to feel safe at home” 
“You don’t deserve to be hit or hurt. It is not your  fault” 
“Thank you for telling me. You are not alone. Help is available” 
“You are not to blame. Abuse is common and happens  in all kinds of 
relationships.” 
 
IRIS ADViSE offers referral to a specialist DVA advocate-educator (AE), who may be available on site 
in the sexual health clinic but is managed by a local DVA service provider. The AE is a unique role 
that provides advocacy for the patient and on-going education for clinicians.  
 
The AE and generic DVA services provide support for current and historic abuse. This includes in-
depth risk assessments, immediate emotional support, access to psychological support services, 
housing, criminal justice, social services, and help to plan safe exits. They also often support relatives 
and friends who are concerned about someone else being affected by DVA. They can also refer to 
MARACs (Multi Agency Risk Assessment Conferences). These aim to develop and implement a 
coordinated safety plan for patients at high risk of murder or serious harm. For women, leaving an 
abusive situation is a high-risk period for violence; expert input facilitates safe exits (20).  
 
STEP 4 RECORD 
There should be a consensus within clinics on how to record DVA. Records should be adapted to 
ensure that abuse can be recorded and coded confidentially, as well as flag DVA disclosures for 
future consultations. Clear medical notes are important as they can support successful prosecution 
of perpetrators. IRIS ADViSE provides the HARK electronic prompt to facilitate this process. 
 
Sexual abuse 
Most sexual abuse occurs within pre-existing intimate relationships (1). Sexual health clinics are 
usually already well-prepared to manage disclosures of sexual abuse. All patients should be offered a 
referral to sexual assault referral centres (SARCs) regardless of whether they want to prosecute. An 
in-depth discussion is beyond the scope of this article and comprehensive clinical management is 




BASHH guidance highlights lesbian, gay, bisexual and transgender communities as particularly 
vulnerable to DVA and potentially less able to access help. In one UK study in sexual health services, 
33.9% of men who have sex with men (MSM) have ever experienced a negative potentially abusive 
behaviour (22); whilst another survey suggested that half had been affected by DVA. MSM who have 
experienced IPV are more likely to be substance misusers, suffer from depression, be HIV positive, 
and have unprotected sex (23). ~25% of women who have sex with women are affected by DVA. Up 
to 80% of the transgender population have been affected by DVA ever (24). Men appear to be less 
likely to take up referrals (25), though it is not understood precisely why. LGBT people may be less 
likely to report to police because of fears of prejudice, being judged or revealing sexual/gender 
identities (26). Despite the relative paucity of evidence into DVA in LGBT communities, we do know 
that sexual health services are better placed to identify these groups than other settings. It is 
appropriate to provide the same response and support described in this article, consistent with 
BASHH and IRIS ADViSE, to these patients, along with specialist knowledge about DVA services that 
provide expert support to LGBT communities 
 
Children & Adolescents 
Exposure to DVA damages the health and development of children, even if they do not directly 
witness the abuse. The clinician should enquire whether children are present in the household and 
explore their risk. The child is at greater risk if they are under seven years old, the mother is 
pregnant or the mother or child has special needs. Adolescents are a highly vulnerable group that 
may be exposed to DVA including IPV and dating violence. It is important to emphasise that 
perpetrators do not necessarily need to be someone sharing a household, but can be anyone with 
whom they have an intimate or family relationship. Where there are concerns regarding children or 
vulnerable adults, safeguarding procedures must be initiated. A judgment about whether a case 
requires safeguarding intervention can be complex. If there is any uncertainty, it should be discussed 
with the safeguarding clinical lead and the trust’s child protection services.  
 
Conclusion 
To deliver comprehensive sexual and reproductive healthcare, all sexual health clinicians should be 
competent in safely and compassionately asking about DVA, responding to disclosures and referring 
to DVA services.  Sexual health services should support professionals by providing training and 
developing links with local DVA services. Further detailed information on DVA on health 
professionals’ training and supervision, risk assessments, MARAC referrals and vulnerable groups can 
be found in the BASHH guidance and the book ‘ABC of Domestic and Sexual Violence’ (15)(27)(28).  
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